NASDAQ · Biotechnology
Geron Corporation (GERN)
$0.87
-4.63%
44
In band
Moving averages
SMA 200$1.41-38.25%
Company profile
Geron Corporation, an advanced stage clinical biopharmaceutical company, focuses on the development and commercialization of therapies for myeloid hematologic neoplasms. The company is headquartered in Foster City, California.
SectorHealthcare
IndustryBiotechnology
Market cap$640.37M
P/E ratioNone
EPS$-0.08
Beta0.611
Dividend yield0.00%
52-week high$2.01
52-week low$0.84
Similar stocks in Biotechnology
BNTX
BioNTech SE
RSI 32
VRTX
Vertex Pharmaceuticals Inc
RSI 43
CRSP
CRISPR Therapeutics AG
RSI 27
IOVA
Iovance Biotherapeutics Inc
RSI 31
CAPR
Capricor Therapeutics Inc
RSI 49
DNA
Ginkgo Bioworks Holdings Inc - Class A
RSI 40
CADL
Candel Therapeutics Inc
RSI 27
ARDX
Ardelyx Inc
RSI 46
ALT
Altimmune Inc
RSI 23
EDIT
Editas Medicine Inc
RSI 30
RSI alerts for GERN
An email when GERN closes below RSI 30 or above 70. Nothing else.
Data last updated 13 November 2026 at 7:15 AM EST